Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROGRAMMA: Individualized Radiotherapy in Locally Advanced Cervical Cancer
NCT03163979Phase 3Unknown
- Sponsor
- Nanjing Medical University
- Start
- Jul 2015
- Primary completion
- Apr 2019
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Cervical Cancer (CC) (4 arms), sponsored by Nanjing Medical University. Primary endpoint: Progression-Free Survival at 3 years. Status: unknown.
02
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT03163979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03163979.